`

Array BioPharma Inc

Pharmaceutical Manufacturing

Specialities :
Small molecule drug discovery and development.
Oncology
Biotechnology
Melanoma
And colorectal cancer
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$225.0M
size-icon Size
51 - 200

Frequently Asked Questions About Array BioPharma Inc

What does Array biopharma inc do?+

Array BioPharma Inc. (NASDAQ: ARRY) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Eight registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics). We have locations in Boulder, CO; Cambridge, MA; and Morrisville, NC

What are Array biopharma inc's specialties? +

Small molecule drug discovery and development.,oncology,biotechnology,melanoma,and colorectal cancer

What is Array biopharma inc's industry? +

Array biopharma inc operates in the Pharmaceutical manufacturing industry.

What is Array biopharma inc's revenue? +

Array biopharma inc's revenue is 11m - 100m

What is Array biopharma inc's company size? +

Array biopharma inc has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.